key: cord-0063398-m8p8dk38
authors: Eastwood, M; Metcalfe, C; Lovett, A; Isles, M
title: 981 Management of Epistaxis During The COVID-19 Pandemic Our Experience
date: 2021-05-04
journal: Br J Surg
DOI: 10.1093/bjs/znab134.105
sha: daa0ae037edb84780fd96855692f8c4c607c40d4
doc_id: 63398
cord_uid: m8p8dk38

INTRODUCTION: Epistaxis is a frequently encountered emergency by ENT services. With the COVID-19 outbreak, examination and procedures on the upper airway may put otolaryngologists at increased risk of infection. ENT UK released new guidance for the management of epistaxis during COVID-19 pandemic to safely manage epistaxis and reduce admissions. We report our experience in managing epistaxis using a locally approved protocol using this guidance. METHOD: Prospective audit of management and outcomes of patients presenting to acute ENT services at a large teaching hospital with epistaxis over a 3-month period. RESULTS: 58 patients attended with epistaxis. Various management strategies were used with 50% managed with non-absorbable packing. 15 cases required admission only 8 solely due to epistaxis. Only 5 cases (8.6%) reported re-bleeding within 30 days with one case (1.7%) requiring readmission. CONCLUSIONS: The current guidance appears to be a safe and effective method for managing epistaxis and minimising the number of admissions which may lead to a permanent shift in epistaxis management.

Results: Professional regulatory bodies impose a duty to act in healthcare emergencies. Yet, formal legal protection has not been codified by a usefulness, interaction quality, reliability, patient satisfaction, and future use of telehealth. Conclusions: This report suggests that a significant proportion of SWI's are iatrogenic related and can be avoided through a rigorous attention to detail in the peri-operative setting. Introduction: Epistaxis is a frequently encountered emergency by ENT services. With the COVID-19 outbreak, examination and procedures on the upper airway may put otolaryngologists at increased risk of infection. ENT UK released new guidance for the management of epistaxis during COVID-19 pandemic to safely manage epistaxis and reduce admissions. We report our experience in managing epistaxis using a locally approved protocol using this guidance. Method: Prospective audit of management and outcomes of patients presenting to acute ENT services at a large teaching hospital with epistaxis over a 3-month period. Results: 58 patients attended with epistaxis. Various management strategies were used with 50% managed with non-absorbable packing. 15 cases required admission only 8 solely due to epistaxis. Only 5 cases (8.6%) reported re-bleeding within 30 days with one case (1.7%) requiring readmission.

ii36 | Posters

Conclusions: The current guidance appears to be a safe and effective method for managing epistaxis and minimising the number of admissions which may lead to a permanent shift in epistaxis management